Update Venetoclax in CLL
Zanubrutinib
Acalabrutinib
Obinutuzumab
(Update) Acalabrutinib in CLL and MCL
UpToDate
Patient Power
Leukemia & Lymphoma Society
NCCN Guidelines for Patients